Our work provided new insights into the potential mechanisms of disease flare and anti-TNF treatment response, new transcriptomic resources of SAID spectrum diseases, and expanded the application of single-cell RNA sequencing technology to new disease areas. The gene discussed is TNF; the disease is glycogen storage disease VI.